TGW101

Tagworks Pharmaceuticals BV · Phase 1 active Small molecule

At a glance

Generic name	TGW101
Sponsor	Tagworks Pharmaceuticals BV
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

TGW101 CI brief — competitive landscape report
TGW101 updates RSS · CI watch RSS
Tagworks Pharmaceuticals BV portfolio CI